Evolent Health, Inc. (EVH) financial statements and ratios from SEC XBRL: revenue $1.88B (latest fiscal year), net margin -28.5%, revenue growth 46.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.88B |
| Net Margin | -28.5% |
| Operating Margin (TTM) | -20.4% |
| Net Debt / EBITDA | -2.6 |
| Revenue Growth (YoY) | 46.9% |
| EPS Growth (YoY) | -43.2% |
| Price / Book | 1.44 |
| Price / Sales | 0.26 |
| Altman Z-Score | -0.40 (distress) |
| Piotroski F-Score | 5/9 |
| Piotroski checks passed | 5 of 9 |
| Industry P/E (Business Services) | 30.0 |
| Sector P/E (Technology) | 34.1 |
EVH overview · EVH earnings · EVH KPIs · EVH documents · EVH ownership · EVH peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.